New hope for a COVID-19 vaccine
Pfizer says its new coronavirus vaccine has proven to be more than 90% effective, and it could be used before the end of the year. Dr. Jon LaPook reports.
Pfizer
Pfizer says COVID vaccine is over 90% effective
Drugmaker Pfizer said its coronavirus vaccine trials are 90% effective. Meanwhile, President-elect Joe Biden announces new COVID-19 plans for the country as the U.S. surpasses 10 million confirmed cases. Internal medicine specialist and immunologist Dr. Neeta Ogden joins CBSN's Elaine Quijano to discuss the latest news about the pandemic.
Two more members of Trump's team test positive for COVID-19
Housing and Urban Development Secretary Ben Carson tested positive for COVID-19 on Monday after attending a White House election night party last week. Mark Meadows, who also attended that party, tested positive last week. The man leading President Trump's post-election legal fight, attorney David Bossie, also revealed his positive diagnosis Monday. Dr. Dara Kass, an emergency room physician and a member of the group Doctors for Biden, spoke to CBSN's "Red & Blue" host Elaine Quijano about the promising news from Pfizer's vaccine trial and the crucial period the U.S. is entering in its efforts to contain the virus.
Pfizer says COVID-19 vaccine is over 90% effective
Drugmaker Pfizer said trials show its vaccine is 90% effective in preventing coronavirus infections, and it could apply for emergency use authorization within weeks. Dr. Jon LaPook has details.
Doctor on Pfizer's COVID-19 vaccine
Emergency care physician Dr. Ron Elfenbein joined CBSN to discuss the latest announcement by Pfizer about its coronavirus vaccine. The company says testing shows its vaccine may be 90% effective.
Pfizer says trials show its COVID vaccine "more than 90% effective"
"We are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis," Pfizer CEO says.
Pfizer says its COVID vaccine is 90% effective
U.S. drugmaker Pfizer said Monday that human trials suggest its coronavirus vaccine is 90% effective at preventing COVID-19 infections in people not known to have had the virus already. Dr. David Agus joins "CBS This Morning" to discuss what this means and what is expected to happen next.
Stocks soar to record on promising vaccine trial results
Investors cheered by positive vaccine trial and growing political certainty following U.S. presidential election.
Pfizer to seek OK for COVID-19 vaccine as soon as next month
Nearly all planned 44,000 participants enrolled in final-stage trial. If found safe, vaccine could see use in November.
Pediatrician on COVID vaccine, Halloween safety
Pfizer is expanding its COVID-19 vaccine trial to include minors, since children as well as adults are susceptible to the virus. Dr. Dyan Hes, a pediatrician in New York City, joins CBSN with more on that plus safety tips for celebrating Halloween in the pandemic.
Why distributing a coronavirus vaccine could be "chaos"
The ultra-cold storage requirement for the vaccines will make it challenging for states to get it to their residents, one expert said.
FDA approves remdesivir as COVID treatment
The Food and Drug Administration approved the antiviral drug remdesivir to treat adults who are hospitalized with COVID-19, although it has not been proven to reduce deaths. Dr. Bob Lahita joins CBSN to discuss that plus the latest developments in the race for a vaccine as coronavirus cases spike around the world.
Logistical hurdles in vaccine distribution
The number of confirmed coronavirus cases across the world has surpassed 40 million, as scientists continue to work on developing vaccines. Emergency care physician Dr. Ron Elfenbein, joined CBSN to discuss what hurdles the U.S. and other countries will face in the process to distribute the urgently needed vaccine.
Pfizer won't seek vaccine authorization before election
Pfizer announced Friday it will apply for FDA emergency use authorization for its COVID-19 vaccine "soon after the safety milestone is achieved in the third week in November." Meg Oliver has details.
Pfizer says COVID-19 vaccine could be ready by late November
Drugmaker won't have enough data on its vaccine's safety and efficacy until after presidential election.
Johnson & Johnson starts trial of one-dose COVID-19 vaccine
Phase 3 test launching Wednesday will be one of the world's biggest vaccine studies, with 60,000 volunteers.
ICYMI: Top takeaways from this week's "Face the Nation"
This week we sat down with Pfizer CEO Albert Bourla and former FDA Commissioner Dr. Scott Gottlieb.
Pfizer CEO says company will know if vaccine works by end of October
Approval of a vaccine, however, will depend on federal regulators, Albert Bourla said.
Transcript: Pfizer CEO Albert Bourla on "Face the Nation"
The following is a transcript of an interview with Pfizer CEO Dr. Albert Bourla that aired Sunday, September 13, 2020, on "Face the Nation."
Pfizer CEO says company will know if vaccine works by end of October
Albert Bourla says the drugmaker has manufactured hundreds of thousands of doses.
Pfizer expects COVID-19 vaccine trial results by October
The pharmaceutical company Pfizer said it should know by the end of October whether its vaccine works. Carter Evans has details.
Exxon Mobil dropped from the Dow after nearly a century
It's being replaced by enterprise software company Salesforce.com in another sign of how much the economy has changed.
The race for a coronavirus vaccine
Several companies are well into Phase 3 of their COVID-19 vaccine trials here in the U.S. Dr. Bob Lahita joins CBSN to discuss their progress, plus whether the coronavirus can be detected in America's wastewater.
Inside the "very cautious" U.S. human trial of a COVID vaccine
A doctor on Pfizer's vaccine safety board says the experimental drug causes only minor reactions, but people are "probably going to need two doses."
Final clinical trials on COVID-19 vaccines
Moderna and Pfizer are the first companies to enter Phase 3 clinical testing on a COVID-19 vaccine in the U.S. Each company plans to blind test 30,000 volunteers in hopes of having results and possibly effective vaccines by the end of the year. Meg Oliver reports.
Tennessee prison system head to resign after failed Christa Pike execution
Live
Senior Trump administration officials met to discuss Iran war at Camp David
Medical plane missing near Nantucket with 6 on board, authorities say
Trump urges daylight saving time bill supporters to personally call Sen. Cotton
Iowa approves pricy foreign-owned steel plant project in swing district
Zach Bryan wears "Free Palestine" shirt during concert at Gillette Stadium
Jane Doe's attorney says "she was incapable of consent," alleges cover-up
More details emerge about FlyDubai co-pilot who tried to crash plane
